Treatment for Macular Degeneration
What is Dry Macular Degeneration, and how can Valeda by LumiThera help?
Age-related Macular Degeneration (AMD) is the most common cause of blindness and poor vision in the UK.
Barnard Levit offers the first approved evidence-based technology for treating and preventing the progression of Dry Age-related Macular Degeneration.
Valeda by LumiThera is the only recommended treatment protocol for patients with Dry AMD.
Valeda uses Photobiomudulation (PBM) to apply specific wavelengths of light to the macula. Clinical trials have revealed benefits in visual function following Valeda.
Treatment for Dry AMD
Valeda Treatment is comprised of 9 sessions over the course of 3 weeks.
Prior to any treatment, your Optometrist will assess the health of your retina and macula, determining a diagnosis.
For more information - please read the Valeda patient leaflet.
To book the Valeda Treatment, please email reception@barnardlevit.com